Events Archive

Bicoll is going Asia

Internationalization strategy of European’s leading Biotech Cluster in Munich grant-aided: Dr. Kai Lamottke, Bicoll, as an industry cluster representative together with Dr. Wehnelt from Bio-M, the networking agency for the biotechnology sector in Munich and Bavaria, have successfully defended the cluster proposal “German-Japanese innovation platform” in front of 14 jury members in Berlin. Read more …

Biotech Press-Lounge in Martinsried

IZB has organized the 1st networking event for biotech companies. Thank you for the publicity supported  by a number of well-known newspapers and reviewers. It was a pleasure be part of Biotech Press Lounge, Martinsried. Great talks, discussions and new contacts.

France: In-cosmetics exhibition

Bicoll visits in-cosmetics exhibition in Paris. Learning more about new and interesting field of cosmetics and going beyond the nutraceuticals and pharmaceuticals. The in-cosmetics group celebrates R&D excellence through its leading events for personal care ingredients across the globe.  Its exhibitions and summit bring together 1000’s of exhibitors of raw materials, fragrances, lab equipment, testing and regulatory solutions …

Academia meets industry

Dr. Kai Lamottke participated in the 31st Symposium organized by Gene Center of the University of Munich (LMU)  and BioM Biotech Cluster Development GmbH.

Bicoll attends IP Summit Berlin 2015

Bicoll is invited to attend IP Summit Berlin 2015. For the tenth year, on 3 and 4 December 2015, Premier Cercle™ will gather 100+ IP high-level speakers and 500+ delegates from corporate, private, institutional and academia worlds at the Pan-European Intellectual Property Summit (IP Summit Berlin). This two-day conference aims at discussing trademark, patent, copyright …

Bicoll Natural Compounds Library: Bio-Europe 2015

Dr. Kai Lamottke joined BIO-Europe 2015 Munich, Germany: Introducing Bicoll Natural Compounds Library. This event is Europe’s largest life science partnering conference with powerful opportunities to network with the right partners and bring together hundreds of the world’s most innovative leaders across biotech, finance and pharma for high-level networking, pre-scheduled partnering meetings, strategic panel discussions …

EpimiRNA: Third General Assembly

Dr. Kai Lamottke presents the results on the topic “New miRNA-Modulating Chemical Entities for the Treatment of Epilepsy” as a workpackage leader of EU-project during the 3rd General Assembly of EpimiRNA. Read more from the project coordinator David Henshall of the Royal College of Surgeons in Ireland Factsheet EpimiRNA.

This Site uses cookies, which could include third-party cookies, to ensure its technical functioning and which may contain tracking information about visitors. By continuing to browse this site you agree to our use of cookies. If you want to learn more about our Privacy Policy click here.